CVE-2026-108797: ZKTeco BioTime authorization bypass in Employee REST API

CVE-2026-108797 · Severity: medium · CVSS 4.3 · Published 2026-10-12

ZKTeco BioTime is a biometric and workforce management system used by organizations to track employee attendance and access. A vulnerability in the Employee REST API allows attackers to bypass authorization controls on employee data, potentially exposing sensitive personnel information without proper credentials. The vulnerability can be exploited remotely over the network.

Technologies: Zkteco BioTime. Vendors: Zkteco.

Quick answers

Is CVE-2026-108797 exploited in the wild?
No. Junglewise Threat Intelligence has no report of CVE-2026-108797 being exploited in the wild.
How severe is CVE-2026-108797?
Medium severity, with a CVSS score of 4.3, published 12 October 2026.
Which products and versions are affected?
Zkteco BioTime 9.5.6 Build 20260130.3206.
Is there a fix for CVE-2026-108797?
Yes: fixed in 9.5.6 Build 3623. Junglewise finds every place you run it, drafts the upgrade and applies it once you approve.
How is CVE-2026-108797 attacked?
It is attacked over the network, in a network appliance.
Am I affected by CVE-2026-108797?
Check whether you run Zkteco BioTime at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.

How to fix

  • Fixed in: 9.5.6 Build 3623

Technical details

An authorization bypass vulnerability exists in the /personnel/api/employees/ endpoint of the Employee REST API component in ZKTeco BioTime 9.5.6 Build 20260130.3206. The vulnerability is triggered via manipulation of unknown code paths in this endpoint, allowing remote attackers to bypass authentication or authorization checks. The fix is available in BioTime 9.5.6 Build 3623 or later.

Affected products

  • ZKTeco BioTime 9.5.6 Build 20260130.3206

Timeline

  • 2026-10-12: disclosed

References

This page as Markdown. Free to reuse under CC BY 4.0 with a link back.